Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.639445
Title: Identification of a C-FABP-PPARγ-VEGF axis promoting tumorigenicity in prostate cancer cells
Author: Seyed Forootan, Farzad
ISNI:       0000 0004 5364 1530
Awarding Body: University of Liverpool
Current Institution: University of Liverpool
Date of Award: 2014
Availability of Full Text:
Access through EThOS:
Access through Institution:
Abstract:
The over-expression of C-FABP plays an important role in promoting tumorigenicity of prostate cancer. It has been hypothesized that the overexpressed C-FABP may transport an excessive amount of intracellular fatty acids into cancer cells to activate their nuclear receptor PPARγ to trigger a chain of molecular events that may lead to a facilitated malignant progression of the cancer cells. To investigate whether PPARγ involved in activities exerted by C-FABP in prostate cancer, their expression status was assessed in prostate cell lines and tissues. Results showed that their expression levels in malignant cell lines and tissues (cytoplasm and nucleus) were significantly higher than those expressed in benign cells and in BPH and it appeared that their expression levels were increased as the increasing malignancies of the cell lines and tissues. The increased expression of both C-FABP and PPARγ were significantly correlated to a reduced survival time. Suppression of PPARγ in highly malignant prostate cancer cells produced a significant reduction in growth rate (up to 53%), invasiveness (up to 89%) and anchorage-independent growth (up to 94%) in vitro. Suppression of PPARγ in PC3-M cells could significantly reduce the sizes of tumours formed in nude mice by 99%. Tumour incidence was reduced to 10% and the latent period was significantly increased by 3.5 fold. The results in this study also showed that C-FABP promoted VEGF expression and angiogenesis by PPARγ (through the stimulation of the fatty acids transported by C-FABP). When PPARγ was blocked with its antagonists, cells did not respond to stimulation signal produced by fatty acids, even when high level of fatty acids was available. Further study showed that the activated PPARγ regulated VEGF expression through acting with the PPREs in the promoter region of VEGF in prostate cancer. Although androgen can modulate VEGF expression through Sp1/Sp3 binding site on VEGF promoter in androgen-dependent prostate cancer cells, this route was disappeared and gradually replcaced by the C-FABP-PPARγ route as the cells gradually lost their androgen dependency. The results of this study suggested that C-FABP, together with fatty acids, PPARγ and VEGF should be considered as key factors in the fatty acids-initiated signalling pathway that promoted the malignant progression. Therefore, the C-FABP-PPARγ-VEGF axis may be a novel therapeutic target for prostatic cancer.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.639445  DOI: Not available
Share: